Management of COVID-19-associated coagulopathy in persons with haemophilia혈우병 환자의 COVID-19 관련 응고병증 관리Article Published on 2021-01-012022-09-12 Journal: Haemophilia : the official journal of the World Fe [Category] MERS, 진단, [키워드] Affect ambulatory patients Antithrombotic bleeding clinical status clotting factor concentrates Coagulopathy complex Complication COVID-19 Diagnosis disease emicizumab Escalation Evidence Factor Guidance haemophilia haemostasis Hospital admission indication individual Infection LMWH management Manifestations pathophysiology Patient prophylactic dose Prophylaxis recommendation responsible risk SARS-CoV-2 supported therapy thromboembolic Thromboprophylaxis thrombosis thrombotic complication Treatment [DOI] 10.1111/hae.14191 PMC 바로가기 [Article Type] Article